EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

Javier Ampuero iD, Rocío Aller, Rocío Gallego-Durán, Javier Crespo, Jose Luis Calleja, Carmelo García-Monzón, Judith Gómez-Camarero, Joan Caballería, Oreste Lo Iacono, Luis Ibañez, Javier García-Samaniego, Agustín Albillos und 19 weitere

Journal of Gastroenterology · 2024-07 · 59 (7) · 586-597

DOI: 10.1007/s00535-024-02098-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology, online erschienen am 15.04.2024. Verfasst von Javier Ampuero und 30 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Seville, Spain. jampuero-ibis@us.es. Hauptthemen laut MEDLINE: Phenotype. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Universidad de Sevilla.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

MASLD can manifest as hepatocellular damage, which can result in mild elevation of aminotransferases. However, in some patients, MASLD presents with cholestatic pattern.

Objective

To assess the impact of the biochemical pattern on the natural course of MASLD, including liver damage in histology, the accuracy of non-invasive tests(NITs), and prognosis.

Methods

Multicenter study enrolling 2156 patients with biopsy-proven MASLD, who were classified based on their[ALT/ULN)]/[(ALP/ULN)] levels at the time of biopsy: (a) hepatocellular pattern(H), > 5; (b) mixed pattern(M),2–5; (c) cholestatic pattern(C), < 2. Outcomes: (a) histological evaluation of the single components of NAS, MASH, and fibrosis; (b) NITs and transient elastography assessing advanced fibrosis; (c) prognosis determined by the appearance of decompensated cirrhosis and death.

Results

Out of the 2156 patients, 22.9% exhibited the H-pattern, whilst 31.7% exhibited the C-pattern. Severe steatosis, ballooning, lobular inflammation, and MASH (56.4% H vs. 41.9% M vs. 31.9% C) were more common in H-pattern ( p = 0.0001),whilst C-pattern was linked to cirrhosis (5.8% H vs. 5.6% M vs. 10.9% C; p = 0.0001). FIB-4(0.74(95% CI 0.69–0.79) vs. 0.83 (95% CI 0.80–0.85); p = 0.005) and Hepamet Fibrosis Score(0.77 (95% CI 0.69–0.85) vs. 0.84 (95% CI 0.80–0.87); p = 0.044)exhibited lower AUROCs in the H-pattern. The C-pattern[HR 2.37 (95% CI 1.12–5.02); p = 0.024], along with age, diabetes, and cirrhosis were independently associated with mortality. Most patients maintained their initial biochemical pattern during the second evaluation.

Conclusions

The H-pattern exhibited greater necro-inflammation in the histology than the C-pattern, whereas the latter showed more cirrhosis. The accuracy of NITs in detecting fibrosis was decreased in H-pattern. The occurrence of decompensated events and mortality was predominant in C-pattern. Therefore, identifying MASLD phenotypes based on the biochemical presentation could be relevant for clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenotypeHumansFemaleMaleMiddle AgedPrognosisAdultAgedLiver CirrhosisBiopsyLiverElasticity Imaging TechniquesAlanine TransaminaseCholestasis

Stichwörter der Autor:innen

CholestasisHepatocellularMASLDPhenotypesTransaminases

Substanzen

Alanine Transaminase

Autor:innen und Institutionen

  • Hospital Universitario Virgen del Rocío, Universidad de Sevilla, Seville, Spain. jampuero-ibis@us.es.
  • SeLiver Group, Instituto de Biomedicina de Sevilla, Seville, Spain. jampuero-ibis@us.es.
  • Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain. jampuero-ibis@us.es.
  • Centro de Investigación de Endocrinología y Nutrición, Hospital Clínico Universitario de Valladolid, Universidad de Valladolid, Valladolid, Spain.
  • SeLiver Group, Instituto de Biomedicina de Sevilla, Seville, Spain.
  • Digestive Disease Department and CIBERehd, Virgen del Rocio University Hospital, Avenida Manuel Siurot S/N, 41013, Seville, Spain.

ORCID-Profile: Javier Ampuero

Förderung

  • Instituto de Salud Carlos III
  • Universidad de Sevilla

Zitieren

APA

Ampuero, J., Aller, R., Gallego-Durán, R., Crespo, J., Calleja, J. L., García-Monzón, C., Gómez-Camarero, J., Caballería, J., Lo Iacono, O., Ibañez, L., García-Samaniego, J., Albillos, A., Francés, R., Fernández-Rodríguez, C., Maya-Miles, D., Diago, M., Poca, M., Andrade, R. J., Latorre, R., …, & HEPAmet Registry (2024). The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis. Journal of Gastroenterology, 59(7), 586-597. https://doi.org/10.1007/s00535-024-02098-8

Vancouver

Ampuero J, Aller R, Gallego-Durán R, Crespo J, Calleja JL, García-Monzón C, et al. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis. Journal of Gastroenterology. 2024;59(7):586-597. doi:10.1007/s00535-024-02098-8

BibTeX
@article{Ampuero2024,
  author = {Ampuero, Javier and Aller, Rocío and Gallego-Durán, Rocío and Crespo, Javier and Calleja, Jose Luis and García-Monzón, Carmelo and Gómez-Camarero, Judith and Caballería, Joan and Lo Iacono, Oreste and Ibañez, Luis and García-Samaniego, Javier and Albillos, Agustín and Francés, Rubén and Fernández-Rodríguez, Conrado and Maya-Miles, Douglas and Diago, Moisés and Poca, Maria and Andrade, Raúl J and Latorre, Raquel and Jorquera, Francisco and Morillas, Rosa María and Escudero, Desamparados and Hernández-Guerra, Manuel and Pareja-Megia, María Jesús and Banales, Jesús M and Aspichueta, Patricia and Benlloch, Salvador and Rosales, José Miguel and Turnes, Juan and Romero-Gómez, Manuel and HEPAmet Registry, HEPAmet Registry},
  title = {The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis},
  journal = {Journal of Gastroenterology},
  year = {2024},
  volume = {59},
  number = {7},
  pages = {586--597},
  doi = {10.1007/s00535-024-02098-8}
}
Kostenlos starten →